Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 12-2018 | 09-2013 | 06-2013 | |
| Sales | 0 | 0 | 0 | 5,205 | 4,956 |
| Cost of Goods | N/A | N/A | N/A | 2,979 | 2,837 |
| Gross Profit | N/A | N/A | N/A | 2,226 | 2,118 |
| Operating Expenses | 20,763 | 28,343 | 0 | 3,741 | 3,308 |
| Operating Income | -20,763 | -28,343 | N/A | -536 | -353 |
| Interest Expense | 935 | 903 | 0 | 0 | 75 |
| Other Income | 744 | 619 | 0 | 151 | 1 |
| Pre-tax Income | -20,954 | -28,627 | 0 | -384 | -426 |
| Net Income Continuous | -20,954 | -28,627 | N/A | -384 | -426 |
| Net Income | $-20,954 | $-28,627 | $N/A | $-385 | $-426 |
| EPS Basic Total Ops | -1.65 | -2.32 | N/A | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -1.65 | -2.32 | N/A | -0.01 | -0.01 |
| EPS Diluted Total Ops | -1.65 | -2.32 | N/A | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -1.65 | -2.32 | N/A | -0.01 | -0.01 |
| EBITDA(a) | $-20,185 | $-28,343 | $N/A | $132 | $294 |